Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02128282
Title Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Senhwa Biosciences, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Scottsdale Arizona 85259-5499 United States Details
University of Colorado- Denver Aurora Colorado 80045 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Texas Oncology-Tyler Tyler Texas 75702 United States Details
Asan Medical Center Seoul Songpa-gu 138-736 Korea, Republic of Details
Samsung Medical Center Seoul Korea, Republic of Details
Seoul National University Hospital Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul Korea, Republic of Details
Chang-Gung Memorial Hospital - Kaohsiung Branch Kaohsiung City Taiwan Details
China Medical University Hospital Taichung City Taiwan Details
National Cheng Kung University Hospitals Tainan City Taiwan Details
National Taiwan University Hospital Taipei City Taiwan Details
Taipei Veterans General Hospital Taipei Taiwan Details
Chang-Gung Memorial Hospital - Linkou Branch Taoyuan City Taiwan Details
*Shaded cells indicate that there was no data available from for the field